Uso da terapia por ondas de choque para o tratamento do linfedema associado ao câncer de mama: uma revisão sistemática
DOI:
https://doi.org/10.11606/issn.2317-0190.v25i4a163839Palavras-chave:
Linfedema Relacionado a Câncer de Mama, Tratamento por Ondas de Choque Extracorpóreas, Drenagem Linfática Manual, ReabilitaçãoResumo
O linfedema associado ao câncer de mama é causa de prejuízo significativo da qualidade de vida deste grupo de pacientes e constitui complicação frequente das intervenções necessárias nesse tipo de câncer. Sabe-se que o tratamento utilizado no linfedema associado ao câncer de mama envolve a Terapia Física Complexa (TFC), cuja eficácia é limitada e não atua diretamente na patogênese dessa comorbidade. Conforme já demonstrado em alguns estudos, o uso da Terapia por Ondas de Choque (TOC) demonstra-se potencialmente benéfico para reduzir o linfedema pela indução de neoangiogênese e linfangiogênese. Objetivo: Avaliar o impacto da TOC no tratamento do linfedema associado ao câncer de mama comparado ao uso da TFC. Métodos: Foram utilizadas as seguintes bases de dados: PubMed/MedLine; BIREME; LILACS; The Cochrane Library e EMBASE, e através de busca manual de artigos. Adotou-se o método de pesquisa PICO e os descritores MeSH ajustados conforme a respectiva base de dados. Resultados: Foram encontrados um total de 262 artigos e selecionados por leitura do título ou resumo um total de 17 estudos. Seis foram excluídos por serem duplicatas, totalizando 11 artigos eleitos para verificação dos critérios de inclusão. Destes, nenhum artigo atendeu ao delineamento da metodologia proposta para esta revisão. Três deles se destacaram por se aproximarem mais da temática proposta e foram discutidos. Conclusão: É necessária a realização de estudos com qualidade metodológica adequada para avaliar o potencial benefício do uso da TOC, visando contribuir para a composição de um tratamento mais eficaz, seguro e que atue na patogênese da doença.
Downloads
Referências
Paiva C, Dutra C. Prevalência de linfedema após tratamento de câncer de mama em pacientes com sobrepeso. Fisioter Pesq.2016;23(3):263-7. DOI: https://doi.org/10.1590/1809-2950/15214123032016
National Cancer Institute [homepage on the Internet]. Bethesda: National Cancer Institute; c2015 [cited 2018 Oct 15]. Available from: https://www.cancer.gov/about-cancer/treatment/side-effects/lymphedema/lymphedema-hp-pdq#link/_20_toc
Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98(5):343-8. DOI: https://doi.org/10.1093/qjmed/hci053
Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol. 2017;24(10):2972-80. DOI: https://doi.org/10.1245/s10434-017-5960-x
Meneses KD, McNees MP. Upper extremity lymphedema after treatment for breast cancer: a review of the literature. Ostomy Wound Manage. 2007;53(5):16-29.
Cebicci MA, Sutbeyaz ST, Goksu SS, Hocaoglu S, Oguz A, Atilabey A. Extracorporeal shock wave therapy for breast cancer-related lymphedema: a pilot study. Arch Phys Med Rehabil. 2016;97(9):1520-1525. DOI: https://doi.org/10.1016/j.apmr.2016.02.019
Paz I, Fréz A, Schiessl L, Ribeiro L, Preis C, Guérios L. Terapia complexa descongestiva no tratamento intensivo do linfedema: revisão sistemática. Fisioter Pesq. 2016;23(3):311-17. DOI: https://doi.org/10.1590/1809-2950/15002623032016
Korpan MI, Crevenna R, Fialka-Moser V. Lymphedema: a therapeutic approach in the treatment and rehabilitation of cancer patients. Am J Phys Med Rehabil. 2011;90(5 Suppl 1):S69-75.
Lymphatic filariasis. Fourth report of the WHO Expert Committee on Filariasis. World Health Organ Tech Rep Ser. 1984;702:3-112.
Markowisk J, Wilcon J, Helm P. Lymphedema incidence after specific postmastectomy therapy. Arch Phys Med Rehabil. 1981;62(9):449-52.
Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, Koifman RJ, et al. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol. 2012;19(8):2580-9.
Brito CMM, Velar CM, Andrade LCTO. Lourencao MIP, Santos PP, Leite VD, et al. Tratamento do linfedema. In: Brito CMM, Bazan M, Pinto C, Baia WM, Battistella LR. Manual de Reabilitação em Oncologia do ICESP. São Paulo: Manole; 2014. p. 415-25.
Casley-Smith JR. Measuring and representing peripheral oedema and its alterations. Lymphology. 1994;27(2):56-70.
Sander AP, Hajer NM, Hemenway K, Miller AC. Upper-extremity ¬volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther. 2002;82(12):1201-12.
Sitzia J. Volume measurement in lymphoedema treatment: examination of formulae. Eur J Cancer Care. 1995;4:11-16.
Bicego D, Brown K, Ruddick M, Storey D, Wong C, Harris SR. Exercise for women with or at risk for breast cancer-related lymphedema. Phys Ther. 2006;86(10):1398-405. DOI: https://doi.org/10.2522/ptj.20050328
Ridner SH, Montgomery LD, Hepworth JT, Stewart BR, Armer JM. Comparison of upper limb volume measurement techniques and arm symptoms between healthy volunteers and individuals with known lymphedema. Lymphology. 2007;40(1):35-46.
Grushina TI. What physiotherapeutic method for the treatment of post-mastectomy lymphedema is the most effective? Vopr Kurortol Fizioter Lech Fiz Kult. 2017;94(4):59-66. DOI: https://doi.org/10.17116/kurort201794459-66
Kubo M, Li TS, Kamota T, Ohshima M, Shirasawa B, Hamano K. Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis. J Vasc Surg. 2010;52(2):429-34. DOI: https://doi.org/10.1016/j.jvs.2010.03.017
Baxter GD, Liu L, Petrich S, Gisselman AS, Chapple C, Anders JJ, et al. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer. 2017;17(1):833. DOI: https://doi.org/10.1186/s12885-017-3852-x
Ioppolo F, Rompe JD, Furia JP, Cacchio A. Clinical application of shock wave therapy (SWT) in musculoskeletal disorders. Eur J Phys Rehabil Med. 2014;50:217-30.
Loske AM. Medical and biomedical applications of shock waves. Cham: Springer; 2017.
Romeo P, Lavanga V, Pagani D, Sansone V. Extracorporeal shock wave therapy in musculoskeletal disorders: a review. Med Princ Pract. 2014;23(1):7-13. DOI: https://doi.org/10.1159/000355472
Liao CD, Xie GM, Tsauo JY, Chen HC, Liou TH. Efficacy of extracorporeal shock wave therapy for knee tendinopathies and other soft tissue disorders: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2018;19(1):278. DOI: https://doi.org/10.1186/s12891-018-2204-6
Girolamo L, Stanco D, Galliera E, Viganò M, Lovati AB, Marazzi MG, et al. Soft-focused extracorporeal shock waves increase the expression of tendon-specific markers and the release of anti-inflammatory cytokines in an adherent culture model of primary human tendon cells. Ultrasound Med Biol. 2014;40(6):1204-15. DOI: https://doi.org/10.1016/j.ultrasmedbio.2013.12.003
Notarnicola A, Moretti B. The biological effects of extracorporeal shock wave therapy (eswt) on tendon tissue. Muscles Ligaments Tendons J. 2012;2(1):33-7.
Vetrano M, d'Alessandro F, Torrisi MR, Ferretti A, Vulpiani MC, Visco V. Extracorporeal shock wave therapy promotes cell proliferation and collagen synthesis of primary cultured human tenocytes. Knee Surg Sports Traumatol Arthrosc. 2011;19(12):2159-68. DOI: https://doi.org/10.1007/s00167-011-1534-9
Visco V, Vulpiani MC, Torrisi MR, Ferretti A, Pavan A, Vetrano M. Experimental studies on the biological effects of extracorporeal shock wave therapy on tendon models. A review of the literature. Muscles Ligaments Tendons J. 2014;4(3):357-61.
Wang CJ. An overview of shock wave therapy in musculoskeletal disorders. Chang Gung Med J. 2003;26(4):220-32.
Waugh CM, Morrissey D, Jones E, Riley GP, Langberg H, Screen HR. In vivo biological response to extracorporeal shockwave therapy in human tendinopathy. Eur Cell Mater. 2015;29:268-80. DOI: https://doi.org/10.22203/eCM.v029a20
Ogden JA, Toth-Kischkat A, Schultheiss R. Principles of shock wave therapy. Clin Orthop Relat Res. 2001;(387):8-17. DOI: https://doi.org/10.1097/00003086-200106000-00003
van der Worp H, van den Akker-Scheek I, van Schie H, Zwerver J. ESWT for tendinopathy: technology and clinical implications. Knee Surg Sports Traumatol Arthrosc. 2013;21(6):1451-8. DOI: https://doi.org/10.1007/s00167-012-2009-3
Cheing GL, Chang H. Extracorporeal shock wave therapy. J Orthop Sports Phys Ther. 2003;33(6):337-43. DOI: https://doi.org/10.2519/jospt.2003.33.6.337
Foldager CB, Kearney C, Spector M. Clinical application of extracorporeal shock wave therapy in orthopedics: focused versus unfocused shock waves. Ultrasound Med Biol. 2012;38(10):1673-80. DOI: https://doi.org/10.1016/j.ultrasmedbio.2012.06.004
Storheim K, Gjersing L, Bolstad K, Risberg MA. Extracorporeal shock wave therapy (ESWT) and radial extracorporeal shock wave therapy (rESWT) in chronic musculoskeletal pain. Tidsskr Nor Laegeforen. 2010;130(23):2360-4. DOI: https://doi.org/10.4045/tidsskr.09.0654
Schmitz C, Császár NB, Milz S, Schieker M, Maffulli N, Rompe JD, et al. Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database. Br Med Bull.2015;116:115-38. DOI: https://doi.org/10.1093/bmb/ldv047
Speed C. A systematic review of shockwave therapies in soft tissue conditions: focusing on the evidence. Br J Sports Med. 2014;48(21):1538-42. DOI: https://doi.org/ 10.1136/bjsports-2012-091961
Zhou H, Wang M, Hou C, Jin X, Wu X. Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema. Jpn J Clin Oncol. 2011;41(7):841-6. DOI: https://doi.org/10.1093/jjco/hyr055
Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis. 2006;17(1):63-70. DOI: https://doi.org/10.1097/00019501-200602000-00011
Katz JE, Molina ML, Clavijo R, Prakash NS, Ramasamy R. A phase 2 randomized trial to evaluate different dose regimens of low-intensity extracorporeal shockwave therapy for erectile dysfunction: clinical trial update. Eur Urol Focus. 2018;4(3):336-337. DOI: https://doi.org/10.1016/j.euf.2018.07.011
Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004;110(19):3055-61. DOI: https://doi.org/10.1161/01.CIR.0000148849.51177.97
Chung E, Cartmill R. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial. BJU Int. 2015;115 Suppl 5:46-9. DOI: https://doi.org/10.1111/bju.13035
Balzarini A, Pirovano C, Diazzi G, Olivieri R, Ferla F, Galperti G, et al. Ultrasound therapy of chronic arm lymphedema after surgical treatment of breast cancer. Lymphology. 1993;26(3):128-34.
Böhm D, Kubitza A, Lebrecht A, Schmidt M, Gerhold-Ay A, Battista M, et al. Prospective randomized comparison of conventional instruments and the Harmonic Focus(®) device in breast-conserving therapy for primary breast cancer.Eur J Surg Oncol. 2012;38(2):118-24. DOI: https://doi.org/10.1016/j.ejso.2011.11.003
Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379-403. DOI: https://doi.org/10.21037/gs.2017.11.04
Kayıran O, De La Cruz C, Tane K, Soran A. Lymphedema: From diagnosis to treatment. Turk J Surg. 2017;33(2):51-57. DOI: https://doi.org/10.5152/turkjsurg.2017.3870
Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat. 2005;92(1):51-60. DOI: https://doi.org/10.1007/s10549-004-5778-7
Kim SY, Bae H, Ji HM. Computed Tomography as an Objective Measurement Tool for Secondary Lymphedema Treated With Extracorporeal Shock Wave Therapy. Ann Rehabil Med. 2015;39(3):488-93. DOI: https://doi.org/10.5535/arm.2015.39.3.488
Bae H, Kim HJ. Clinical outcomes of extracorporeal shock wave therapy in patients with secondary lymphedema: a pilot study. Ann Rehabil Med. 2013;37(2):229-34. DOI: https://doi.org/10.5535/arm.2013.37.2.229
Imboden S, Herzig D, Rabaglio M, Hohermuth R, Mueller MD, Günthert AR, et al. Abstract P1-01-14: Extracorporeal shock wave therapy for lymphedema after axillary lymphadenectomy. Cancer Res 2013;73(24 Suppl):P1-01-14.
Ogden JA, Tóth-Kischkat A, Schultheiss R. Principles of shock wave therapy. Clin Orthop Relat Res. 2001;(387):8-17. DOI: https://doi.org/10.1097/00003086-200106000-00003
Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277-84. DOI: https://doi.org/10.1056/NEJMra072149
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2018 Acta Fisiátrica
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
